Anxiety and Related Sleep Disorders - France

Revenue in the Anxiety and Related Sleep Disorders market is projected to reach US$230.50m in 2024.
Revenue is expected to show an annual growth rate (CAGR 2024-2029) of -0.09%, resulting in a market volume of US$229.50m by 2029.
In global comparison, most revenue will be generated United States (US$3.21bn in 2024).
In relation to total population figures, per person revenues of US$42.89 are generated in 2024.

The Anxiety and Related Sleep Disorders market covers sales of three drug classes: anxiolytics, hypnotics, and sedatives. These classes contain different types of drugs, such as benzodiazepines, anticonvulsants, and antihistamines, that reduce anxiety and insomnia symptoms caused by anxiety. These medications mainly fall into the category of prescription drugs.

Market values represent the revenues generated by manufacturers and are based on retail prices for each drug category including all drugs, regardless of whether they are reimbursed or not.

Company examples: Pfizer, Bristol-Myers Squibb, GlaxoSmithKline PLC, Johnson & Johnson, and Merck & Co.

Pharmaceutical sales and consumption of anxiolytics
Pharmaceutical sales and consumption hypnotics and sedatives

Non-mental health related sleep disorders
Any other anxiety medications
Psychotherapy

The Anxiety and Related Sleep Disorders market in France is experiencing significant growth and development.

Customer preferences: In recent years, there has been an increasing demand for products and services that address anxiety and related sleep disorders in France. This can be attributed to several factors, including the growing awareness and understanding of mental health issues, as well as the availability of a wide range of treatment options. Customers are now more willing to seek help and invest in products and services that can improve their mental well-being.

Trends in the market: One of the key trends in the Anxiety and Related Sleep Disorders market in France is the rising popularity of natural and holistic remedies. Customers are increasingly looking for alternative treatments that do not involve medication or have minimal side effects. This has led to a surge in the demand for products such as herbal supplements, aromatherapy oils, and relaxation techniques like yoga and meditation.Another trend in the market is the integration of technology in the treatment of anxiety and related sleep disorders. Mobile applications and wearable devices that track sleep patterns, provide guided meditation sessions, and offer cognitive behavioral therapy exercises have gained popularity among customers. These technological advancements have made it easier for individuals to access treatment and manage their symptoms from the comfort of their own homes.

Local special circumstances: France has a strong healthcare system that provides comprehensive coverage for mental health services. This has played a significant role in driving the growth of the Anxiety and Related Sleep Disorders market in the country. The accessibility and affordability of treatment options have encouraged more individuals to seek help for their mental health issues.Additionally, France has a culture that values work-life balance and self-care. This has created a conducive environment for the growth of the Anxiety and Related Sleep Disorders market, as individuals are more willing to invest in products and services that promote their mental well-being.

Underlying macroeconomic factors: The overall economic stability and growth in France have also contributed to the development of the Anxiety and Related Sleep Disorders market. As individuals have more disposable income, they are able to allocate a portion of their budget towards products and services that address their mental health needs.Furthermore, the COVID-19 pandemic has had a significant impact on the Anxiety and Related Sleep Disorders market in France. The uncertainty and stress caused by the pandemic have led to an increase in the number of individuals seeking help for anxiety and sleep disorders. This has further fueled the growth of the market, as more people are recognizing the importance of mental well-being during challenging times.In conclusion, the Anxiety and Related Sleep Disorders market in France is experiencing growth and development due to customer preferences for natural remedies and technological advancements, as well as the country's strong healthcare system and cultural emphasis on self-care. The underlying macroeconomic factors, such as economic stability and the impact of the COVID-19 pandemic, have also contributed to the market's growth.

Data coverage:

Data encompasses B2C enterprises. Figures are based on companies' revenues, international institutes data, and global consumer survey data. Revenues refer to the retail value and include sales taxes.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use financial reports and third-party data. Next, we use relevant key market indicators and data from country-specific associations such as healthcare spending per capita, medical product spending per capita, and gross domestic product per capita. This data helps us to estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, S-Curve function, ARIMA time series model and exponential curve function. Data is modeled using current exchange rates.

Additional Notes:

The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. GCS data is reweighted for representativeness.

This report presents a comprehensive analysis and additional information on the Health market, in a PDF format.

Despite what some may think, mental health problems are common in the United States and around the world. Mental health issues, much like other health issues, can be mild, but can also be life altering, affecting the emotional, social, and psychological well-being of the person. Common types of mental illness include mood disorders, anxiety disorders, eating disorders, and personality disorders. Although symptoms of mental illness differ depending on the type of illness and seriousness of the problem, common symptoms of mental health issues include changes in sleeping and eating habits, social withdrawal, feelings of hopelessness, anger, and prolonged sadness, suicidal thoughts, and substance abuse. In 2022, it was estimated that around 36 percent of those in the U.S. aged 18 to 25 years and 29 percent of those aged 26 to 49 years suffered from some form of mental illness in the past year.